Concord Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.8K | Buy |
113
+32
| +40% | +$13K | 0.01% | 354 |
|
|
2025
Q1 | $40.3K | Sell |
81
-9
| -10% | -$4.48K | 0.01% | 347 |
|
|
2024
Q4 | $46.8K | Sell |
90
-3
| -3% | -$1.56K | 0.01% | 340 |
|
|
2024
Q3 | $57.5K | Buy |
93
+8
| +9% | +$4.95K | 0.01% | 317 |
|
|
2024
Q2 | $47K | Sell |
85
-53
| -38% | -$29.3K | 0.01% | 319 |
|
|
2024
Q1 | $80.2K | Sell |
138
-164
| -54% | -$95.3K | 0.01% | 291 |
|
|
2023
Q4 | $160K | Sell |
302
-582
| -66% | -$309K | 0.03% | 222 |
|
|
2023
Q3 | $447K | Buy |
884
+80
| +10% | +$40.5K | 0.1% | 131 |
|
|
2023
Q2 | $420K | Buy |
804
+274
| +52% | +$143K | 0.09% | 125 |
|
|
2023
Q1 | $305K | Buy |
530
+52
| +11% | +$30K | 0.09% | 115 |
|
|
2022
Q4 | $263K | Sell |
478
-269
| -36% | -$148K | 0.08% | 135 |
|
|
2022
Q3 | $379K | Sell |
747
-19
| -2% | -$9.64K | 0.12% | 110 |
|
|
2022
Q2 | $416K | Buy |
766
+124
| +19% | +$67.3K | 0.11% | 115 |
|
|
2022
Q1 | $379K | Buy |
642
+32
| +5% | +$18.9K | 0.1% | 122 |
|
|
2021
Q4 | $407K | Buy |
610
+343
| +128% | +$229K | 0.1% | 115 |
|
|
2021
Q3 | $153K | Sell |
267
-264
| -50% | -$151K | 0.06% | 106 |
|
|
2021
Q2 | $268K | Buy |
531
+63
| +13% | +$31.8K | 0.08% | 110 |
|
|
2021
Q1 | $214K | Buy |
468
+343
| +274% | +$157K | 0.07% | 125 |
|
|
2020
Q4 | $58K | Buy |
+125
| New | +$58K | 0.04% | 189 |
|